Xiaoye Li

1.2k total citations
102 papers, 842 citations indexed

About

Xiaoye Li is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoye Li has authored 102 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 29 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoye Li's work include Antiplatelet Therapy and Cardiovascular Diseases (20 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Cardiac Arrhythmias and Treatments (14 papers). Xiaoye Li is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (20 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Cardiac Arrhythmias and Treatments (14 papers). Xiaoye Li collaborates with scholars based in China, Singapore and France. Xiaoye Li's co-authors include Qing Xu, Li Fan, Shengyong Zhang, Hong Wu, Qian Yang, Chunhu Gu, Ying Xue, Chong Cheng, Yukun Wang and Fei Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xiaoye Li

92 papers receiving 832 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoye Li China 15 227 212 130 117 113 102 842
Magdalena Boncler Poland 18 315 1.4× 216 1.0× 67 0.5× 37 0.3× 146 1.3× 48 966
V. M. Berlin Grace India 20 146 0.6× 584 2.8× 81 0.6× 77 0.7× 52 0.5× 59 1.2k
Mei Yang China 20 366 1.6× 348 1.6× 233 1.8× 113 1.0× 62 0.5× 63 1.3k
Xiaxia Wu China 10 84 0.4× 283 1.3× 72 0.6× 66 0.6× 38 0.3× 16 629
Qingqing Xiao China 18 46 0.2× 392 1.8× 113 0.9× 92 0.8× 79 0.7× 50 995
Masahiro Hamada Japan 18 115 0.5× 186 0.9× 142 1.1× 91 0.8× 32 0.3× 74 874
Yuguang Wang China 13 129 0.6× 233 1.1× 69 0.5× 33 0.3× 40 0.4× 49 975
Jinxin Li China 16 68 0.3× 220 1.0× 61 0.5× 47 0.4× 65 0.6× 67 775
Yue Gao China 17 50 0.2× 232 1.1× 91 0.7× 70 0.6× 39 0.3× 68 795
Bikash Manandhar Australia 17 40 0.2× 417 2.0× 58 0.4× 92 0.8× 122 1.1× 35 1.0k

Countries citing papers authored by Xiaoye Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoye Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoye Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoye Li more than expected).

Fields of papers citing papers by Xiaoye Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoye Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoye Li. The network helps show where Xiaoye Li may publish in the future.

Co-authorship network of co-authors of Xiaoye Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoye Li. A scholar is included among the top collaborators of Xiaoye Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoye Li. Xiaoye Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaoxiao, Xiaoye Li, Yimin Zhou, et al.. (2025). Tetramethylpyrazine exerts a neuroprotective effect in acute spinal cord injury by mitigating oxidative stress through PKD1: Multi-omics analysis and experimental validation. European Journal of Pharmacology. 998. 177514–177514. 1 indexed citations
2.
Ding, Meng, Yu Zhang, Xiaoye Li, et al.. (2024). Simultaneous Biofilm Disruption, Bacterial Killing, and Inflammation Elimination for Wound Treatment Using Silver Embellished Polydopamine Nanoplatform. Small. 20(36). e2400927–e2400927. 22 indexed citations
3.
Li, Xiaoye, Liangxi Yuan, Lei Zhang, et al.. (2024). Stent-graft implantation for late postpancreatectomy hemorrhage after pancreatoduodenectomy. Chinese Journal of Traumatology. 28(1). 7–12.
4.
Li, Qiang, Meng Dang, Xiaoye Li, et al.. (2024). Extracellular Vesicle‐Inspired Minimalist Flexible Nanocapsules Assembled with Whole Active Ingredients for Highly Efficient Enhancement of DC‐Mediated Tumor Immunotherapy. Advanced Healthcare Materials. 13(31). e2401199–e2401199. 4 indexed citations
5.
6.
Li, Xiaoye, Haoran Su, Shuman Zhang, et al.. (2024). Highly stable color-tunable organic long-persistent luminescence from a single-component exciplex copolymer for in vitro antibacterial. Chemical Science. 15(36). 14880–14887. 5 indexed citations
8.
10.
Li, Xiaoye, et al.. (2023). Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation. Cardiovascular Drugs and Therapy. 38(6). 1315–1325. 6 indexed citations
11.
Liu, Zehou, Xiaofei Ma, Hongshen Wan, et al.. (2023). Characterization and Differentiation of Grain Proteomes from Wild-Type Puroindoline and Variants in Wheat. Plants. 12(10). 1979–1979. 2 indexed citations
12.
Song, Chao, et al.. (2022). Novel Endovascular Interventional Surgical Robotic System Based on Biomimetic Manipulation. Micromachines. 13(10). 1587–1587. 10 indexed citations
13.
Wen, Dan, Yanan Zhang, Xiaoye Li, et al.. (2022). Suppression of flavivirus transmission from animal hosts to mosquitoes with a mosquito-delivered vaccine. Nature Communications. 13(1). 7780–7780. 14 indexed citations
14.
Li, Xiaoye, et al.. (2022). Effectiveness and safety of sacubitril/valsartan for patients with hypertension and heart failure in the real‐world setting: A retrospective study in China. Journal of Clinical Pharmacy and Therapeutics. 47(10). 1539–1547. 6 indexed citations
15.
Li, Xiaoye, et al.. (2022). Evaluation of pharmacist-led telemedicine medication management for hypertension established patients during COVID-19 pandemic: A pilot study. Frontiers in Public Health. 10. 1091484–1091484. 9 indexed citations
16.
Li, Xiaoye, Chao Song, Hao Zhang, et al.. (2021). Long-Term Outcomes of Thoracic Endovascular Repair for Aortic Arch Dissection Using Customized Single-Branched Fenestrated Stent-Graft. Vascular and Endovascular Surgery. 55(6). 577–585. 9 indexed citations
17.
Xue, Ying, Ziheng Hu, Yankang Jing, et al.. (2020). Efficacy assessment of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention by data mining and machine‐learning decision tree approaches. Journal of Clinical Pharmacy and Therapeutics. 45(5). 1076–1086. 9 indexed citations
18.
Wang, Zi, et al.. (2020). Genetic Polymorphisms and Perioperative Bleeding in Off-Pump Coronary Artery Bypass Grafting Surgery. The Annals of Thoracic Surgery. 112(1). 116–123. 2 indexed citations
19.
Li, Xiaoye, et al.. (2019). Report on the Development of China’s Publishing Industry in 2018. Publishing Research Quarterly. 35(4). 543–561. 2 indexed citations
20.
Li, Xiaoye. (2003). Determination of Borneol in Blood After Keeping Suxiao Jiuxin Pills in Healthy People's Mouth by GC. Zhongguo yaofang. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026